K J Anstrom
Overview
Explore the profile of K J Anstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grotegut C, Kuklina E, Anstrom K, Heine R, Callaghan W, Myers E, et al.
BJOG
. 2014 Mar;
121(11):1386-94.
PMID: 24661593
Objective: Cardiomyopathy (CM) at delivery is increasing in prevalance. The objective of this study was to determine which medical conditions are attributable to this increasing prevalance. Design: Population prevalence study...
2.
Olsen E, Callender V, Sperling L, McMichael A, Anstrom K, Bergfeld W, et al.
Dermatol Ther
. 2008 Aug;
21(4):264-7.
PMID: 18715296
Central centrifugal cicatricial alopecia (CCCA) is a common but poorly understood cause of hair loss in African American women. A photographic scale was developed that captures the pattern and severity...
3.
Weinfurt K, Anstrom K, Castel L, Schulman K, Saad F
Ann Oncol
. 2006 Mar;
17(6):986-9.
PMID: 16533874
Background: Zoledronic acid reduces skeletal-related events associated with prostate cancer and has long-term efficacy in pain outcomes. Findings of treatment group differences in pain early in treatment are less reliable....
4.
Anstrom K, Tsiatis A
Biometrics
. 2002 Jan;
57(4):1207-18.
PMID: 11764262
Observational studies frequently are conducted to compare long-term effects of treatments. Without randomization, patients receiving one treatment are not guaranteed to be prognostically comparable to those receiving another treatment. Furthermore,...
5.
Eisenstein E, Shaw L, Anstrom K, Nelson C, Hakim Z, Hasselblad V, et al.
Med Care
. 2001 Jul;
39(8):824-35.
PMID: 11468501
Background: The acute phase of coronary artery disease (CAD) is dramatic and receives much attention because of its high mortality and associated treatment cost. However, the acute phase typically resolves...
6.
Holman W, Allman R, Sansom M, Kiefe C, Peterson E, Anstrom K, et al.
JAMA
. 2001 Jun;
285(23):3003-10.
PMID: 11410099
Context: Efforts to improve quality of care in the cardiac surgery field have focused on reducing the risk-adjusted mortality associated with common surgical procedures, such as coronary artery bypass grafting...
7.
Mast S, Gersing K, Anstrom K, Krishnan K, Califf R, Jollis J
Am J Cardiol
. 2001 Apr;
87(8):989-93: A4.
PMID: 11305992
The identification of an association between fenfluramines and valvular disease has raised the possibility of a similar association between another class of medications that increases local levels of serotonin, the...
8.
Mast S, Jollis J, Ryan T, Anstrom K, Crary J
Ann Intern Med
. 2001 Feb;
134(4):261-6.
PMID: 11182835
Background: An association between the dietary suppressants fenfluramine and dexfenfluramine and valvular heart disease was first described in patients from North Dakota and Minnesota in 1997. Limited data are available...
9.
Batchelor W, Anstrom K, Muhlbaier L, Grosswald R, Weintraub W, ONeill W, et al.
J Am Coll Cardiol
. 2000 Sep;
36(3):723-30.
PMID: 10987591
Objectives: We sought to define the risks facing octogenarians undergoing contemporary percutaneous coronary interventions (PCIs). Background: The procedural risks of PCI for octogenarians have not been well established. Methods: We...
10.
Alexander K, Anstrom K, Muhlbaier L, Grosswald R, Smith P, Jones R, et al.
J Am Coll Cardiol
. 2000 Mar;
35(3):731-8.
PMID: 10716477
Objectives: The purpose of this study was to evaluate characteristics and outcomes of patients age > or =80 undergoing cardiac surgery. Background: Prior single-institution series have found high mortality rates...